1. Home
  2. FTEK vs CTSO Comparison

FTEK vs CTSO Comparison

Compare FTEK & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fuel Tech Inc.

FTEK

Fuel Tech Inc.

HOLD

Current Price

$1.37

Market Cap

42.0M

Sector

Industrials

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.64

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTEK
CTSO
Founded
1987
1997
Country
Employees
N/A
N/A
Industry
Pollution Control Equipment
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
45.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FTEK
CTSO
Price
$1.37
$0.64
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$4.00
$5.38
AVG Volume (30 Days)
178.6K
79.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.16
$7.29
Revenue Next Year
$21.36
$8.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$0.60
52 Week High
$3.65
$1.39

Technical Indicators

Market Signals
Indicator
FTEK
CTSO
Relative Strength Index (RSI) 46.43 43.83
Support Level $1.25 $0.62
Resistance Level $1.48 $0.67
Average True Range (ATR) 0.10 0.05
MACD 0.01 -0.00
Stochastic Oscillator 56.52 13.55

Price Performance

Historical Comparison
FTEK
CTSO

About FTEK Fuel Tech Inc.

Fuel Tech Inc is an technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: